• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

News 2 Business

Your Leading Business News Source

NEWS 2 BUSINESS
Your Leading Business News Source

  • Home
  • BUSINESS
  • REAL ESTATE
  • About/Contact

Seaweed molecules used to improve outcomes for bypass surgery — ScienceDaily

December 5, 2022 by Staff Reporter

Researchers are using a natural material derived from seaweed to promote vascular cell growth, prevent blood clots and improve the performance of synthetic vascular grafts used in heart bypass surgery.

The new approach, developed and tested at the University of Waterloo, is especially important in cases involving small artificial blood vessels — those less than six millimetres in diameter — which are prone to clots that can develop into full blockages.

“There is a crucial need to develop synthetic vascular graft materials that will increase the rate of long-term functions,” said Dr. Evelyn Yim, a chemical engineering professor and University Research Chair who leads the project.

Researchers added a material called fucoidan, which is made from seaweed, to modify synthetic blood vessels. Fucoidan has a structure similar to heparin, a drug used as an anticoagulant.

When applied with a nanotechnology technique known as micropatterning, fucoidan promotes the growth of vascular cells around the inner surface of the graft, significantly reducing the chances of clots forming.

For patients, the potential benefits include fewer complications, better quality of life and less risk of the recurrence of blockages requiring additional drug treatment or surgery.

“A functional, off-the-shelf, small-diameter vascular graft will help save lives,” said Yim, director of the Regenerative Nanomedicine Lab at Waterloo. “What’s important is that they will be much longer-lasting and allow blood to flow freely.”

Bypass surgery is performed to restore blood flow to areas of the heart when vessels become blocked. Vessels harvested from the patient are the gold standard for grafts, but limited availability often requires the use of artificial vessels.

In addition to heart bypass surgery, grafts are used in medical procedures to treat vascular diseases and restore blood flow to vital organs and tissues, including the brain and legs.

When synthetic graft material doesn’t allow vascular cells to grow on the inside of an artery or vessel, there is a high chance of clots, which can develop into full blockages or cause inflammation that restricts blood flow.

Yim has successfully tested the new technique using fucoidan and micropatterning on small animals and plans to expand to large animal testing before advancing to clinical trials.

Several researchers from the Department of Chemical Engineering at Waterloo and the Department of Biomedical Engineering at the Oregon Health and Science University have collaborated on this project.

Story Source:

Materials provided by University of Waterloo. Note: Content may be edited for style and length.

>>> ad: Don't Miss Today's BEST Amazon Deals!
Originally Appeared Here

Filed Under: TECH/SCIENCE

Primary Sidebar

Recent Posts

  • DeFronzo receives global award for pioneering diabetes research
  • In a First, Medicaid Extends Coverage to Prison Inmates – Consumer Health News
  • Life after leprosy, a long neglected disease, Health News, ET HealthWorld
  • Curious about intermittent fasting? Here’s what experts say you should know
  • Tyre Nichols video raises concerns about impact on viewers’ mental health

Recent Comments

    Privacy Policy | Terms and Conditions | About/ Contact
    As an Amazon Associate I earn from qualifying purchases.

    Copyright © 2023 · NEWS 2 BUSINESS . Log in